Tag: FDA decision on weight loss drug shortage
FDA Reconsiders Removing Eli Lilly Weight Loss Drug from Shortage List
The Food and Drug Administration, or FDA, announced on Friday that it would be revisiting its decision to remove Eli Lilly's tirzepatide, which is known as Mounjaro for diabetes and Zepbound for obesity, from...